A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next‐generation sequencing hereditary pan‐cancer panel are acquired somatically

Previous analysis of next‐generation sequencing (NGS) hereditary pan‐cancer panel testing demonstrated that approximately 40% of TP53 pathogenic and likely pathogenic variants (PVs) detected have NGS allele frequencies between 10% and 30%, indicating that they likely are acquired somatically. These...

Descripción completa

Detalles Bibliográficos
Autores principales: Coffee, Bradford, Cox, Hannah C., Bernhisel, Ryan, Manley, Susan, Bowles, Karla, Roa, Benjamin B., Mancini‐DiNardo, Debora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972517/
https://www.ncbi.nlm.nih.gov/pubmed/31490007
http://dx.doi.org/10.1002/humu.23910

Ejemplares similares

Ejemplares similares